Psychologists in Tuckahoe, NY Accepting Medicare
10 Psychologists found. Showing 1 - 10
 Dr. Thomas Aquinas Fischer, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 111 Lake Avenue Suite 4, Tuckahoe, NY 10707 Phone: 914-793-7708 |
 Dr. Susan Hardwick Fischer, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 111 Lake Avenue, Ste 4, Tuckahoe, NY 10707 Phone: 914-793-7708 |
John Stokes, PH.D. Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 410 Read Ave, Tuckahoe, NY 10707 Phone: 914-793-8998 |
Dr. Vivian Khedari Depierro, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 94 Maple Ave, Tuckahoe, NY 10707 Phone: 914-296-4335 |
Dr. Faith Deveaux, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1 Elm St, Suite 2c, Tuckahoe, NY 10707 Phone: 914-961-9100 |
Dr. Arthur Henry Lilling, PHD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 111 Lake Avenue, Suite 4, Tuckahoe, NY 10707 Phone: 914-337-2044 |
Dr. Nancy B. Eisenman, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 16 Hollywood Ave. E, Tuckahoe, NY 10707 Phone: 914-337-0135 Fax: 914-337-0135 |
Dr. Andrea Malter Lilling, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 111 Lake Avenue, Suite 4, Tuckahoe, NY 10707 Phone: 914-337-2044 |
Paula Bernstein, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 111 Lake Ave, Suite 4, Tuckahoe, NY 10707 Phone: 914-793-0533 |
Dr. Sara Schloss Stave, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 77 Highview Ave, Tuckahoe, NY 10707 Phone: 914-793-7770 Fax: 914-793-8011 |
News Archive
CBio recruits 75th patient into XToll phase II clinical trial, achieves milestone under agreement with Novo Nordisk
Australian drug development company CBio Limited today announced the achievement of a clinical trial milestone under its option agreement with global pharmaceutical leader Novo Nordisk A/S. The agreement relates to the development of XToll, the potential new-generation drug therapy which could provide safer and more effective treatment of autoimmune diseases such as rheumatoid arthritis (RA).
Anadis licenses antibody technologies from ImmuCell
Anadis Limited, an Australian-based biotechnology company focused on milk derived polyclonal antibodies and other milk-derived bioactives, announced today that it had signed a final agreement with ImmuCell Corporation, a biotechnology company headquartered in Portland, Maine, USA.
Telephone delivered program improves health outcomes for people diagnosed with bowel cancer
They say a phone call can change your life and for colorectal or bowel cancer survivors this is true, a new study by a QUT researcher has found.
TSRI scientists receive $3.3 million NIH grant to create new breast cancer treatments
A pair of scientists from the Florida campus of The Scripps Research Institute have been awarded up to $3.3 million from the National Cancer Institute of the National Institutes of Health to create the next generation of breast cancer treatments for the thousands of patients whose current treatment options are limited.
› Verified 3 days ago
Dentists
Counselors
Psychologists
Clinical Social Workers
Pharmacists
Occupational Therapists